Notice of temporary programme suspension
As a result of ongoing developments regarding Coronavirus (COVID-19), the NHS Leadership Academy’s leadership development programmes are suspended from 17 March 2020, for 16 weeks in the first instance.
This is not a step that we have taken lightly but given the unique nature of our programme participants being drawn from the NHS workforce and wider health and care, and in response to concerns that have been raised, it is both a compassionate and practical step. This ensures that we are all able to fully support the vital work required to manage the Coronavirus (COVID-19) situation.
The current national focus is to reduce the progression of the virus through social distancing, so it’s now more important than ever, that we all focus on service delivery, helping local health and care services to provide patients with the care and information they need to stay safe and well.
We recognise that in addition to the roles of our programme participants, be they patient facing or otherwise, we all have a wider societal role and responsibility to reduce infection rates where possible, and that we all also have families or loved ones for whom we may need to care.
The programmes affected together with their contact details are:
Aspiring Chief Executive
Chief Executive Development Network
Clinical Executive Fast Track Scheme
Diversity, Inclusion, Power and Practice (DIPP) [email protected]
Elizabeth Garrett Anderson [email protected]
Graduate Management Training Scheme (face-to-face educational and residential elements suspended only) [email protected]
Health and Care Leaders Scheme (HCLS) 2025 [email protected]
If you are currently a participant on one of these programmes, you should have already received a direct communication from the NHS Leadership Academy informing you of the situation. If not, please contact your programme co-ordinator through your usual contact route or via the relevant email address above.
For all other enquiries, you can contact us on 0113 3225699 or email [email protected]
Further information will be provided in due course.